FDAnews
www.fdanews.com/articles/101610-astrazeneca-s-breast-cancer-drug-gets-6-month-extension

AstraZeneca's Breast Cancer Drug Gets 6-Month Extension

November 29, 2007
AstraZeneca said the U.S. Food and Drug Administration has granted a six-month extension to the exclusivity patent for the marketing of its breast cancer drug Arimidex.
Hemscott